- March 04, 2024Source: Newsweek
Woman Who Worked Out 5 Times A Week Shocked After Finding Lump
- February 06, 2024Source: CNN
Dr. Megan Ranney on King Charles' Cancer Diagnosis and the Importance of Regular Screenings
- February 06, 2024Source: CGTN America
Dr. Chen Xi Discusses Sharp Rise in Cancer Cases
- February 05, 2024
Dr. Caroline Johnson on Yale Cancer Answers
Cancer
More people today die from cancer than from almost any other cause in the world. The challenges posed by cancer are immense and top scientists at the Yale School of Public Health are committed to reducing its toll.
The departments of Chronic Disease Epidemiology, Biostatistics and Health Policy and Management are heavily focused on a wide variety of cancer-related research, and the Department of Environmental Health Sciences is renowned for novel approaches to the study of how environmental exposures affect health outcomes. From key partnerships with the Yale Cancer Center to collaborative efforts locally and globally, YSPH scientists are taking significant steps toward preventing and treating a wide range of cancers. Today, research in cancer and other chronic diseases encompasses interdisciplinary teams committed to understanding cancer causation and etiology, prevention, screening and early detection, risk factors, environmental exposures, social determinants of health and survival.
A variety of technologies and approaches are used to detect mechanisms and characteristics of the many different types of cancer, including genomics, metabolomics, social and behavioral effects, evolutionary biology, biostatistical methodology and study design, and outcomes research.
The Yale School of Public Health maintains biospecimens and data from thousands of individuals in more than a dozen studies that can be made applied to future research. It also has partnerships with numerous international cancer researchers, and is the home of leading experts in clinical trial design and data management, and genomic and metabolic centers.
Recent Publications
-
American Journal of Preventive Medicine
Impact of the Affordable Care Act on Colorectal Cancer Incidence and Mortality
-
JAMA Network Open
Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database
-
Journal of Clinical Oncology
Cost-Effectiveness of Adjuvant Treatment for Ductal Carcinoma In Situ
-
Journal of Gynecological Oncology
Randomized trial of exercise on depressive symptomatology and brain derived neurotrophic factor (BDNF) in ovarian cancer survivors: The Women's Activity and Lifestyle Study in Connecticut (WALC)
- Public Health Reports
Trends in Precancerous Cervical Lesions by Area-Based Measures of Poverty, Race, and Ethnicity, Connecticut, 2008-2018
Centers and other resources
- Yale Cancer Center (YCC)The Center provides the best approaches for the prevention, detection, diagnosis, and treatment of cancer.
- Yale Center for Analytical Sciences (YCAS)YCAS collaborative team provides expertise in the design, conduct, and analysis of health and health care studies, methodological development, and education and training.
- Yale-Griffin Prevention Research Center (PRC)The PRC works with community partners to develop and implement community-based approaches to prevent and control chronic diseases such as heart disease, diabetes, and cancer.
YSPH Cancer 2022 Research Highlights
- Molecular Biology and EvolutionAttribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes
- International Journal of CancerA competing risk analysis of adherence to the American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention and obesity-related cancer risk in Hispanic/Latino adults in the NIH-AARP Diet and Health Study
- Biology of Sex DifferencesBile acid distributions, sex-specificity, and prognosis in colorectal cancer
- Cancer Epidemiology, Biomarkers & PreventionHispanic Ethnicity Differences in Birth Characteristics, Maternal Birthplace, and Risk of Early-Onset Hodgkin Lymphoma: A Population-Based Case-Control Study